INTERTAPE POLYMER GROUP INC. | |||
Date: May 10, 2018 | By: | /s/ Jeffrey Crystal | |
Jeffrey Crystal, Chief Financial Officer |
Three months ended March 31, | ||||||
2018 | 2017 | |||||
$ | $ | |||||
Revenue | 237,229 | 207,120 | ||||
Cost of sales | 186,777 | 157,980 | ||||
Gross profit | 50,452 | 49,140 | ||||
Selling, general and administrative expenses | 29,123 | 25,974 | ||||
Research expenses | 3,221 | 2,978 | ||||
32,344 | 28,952 | |||||
Operating profit before manufacturing facility closures, restructuring and other related charges | 18,108 | 20,188 | ||||
Manufacturing facility closures, restructuring and other related charges | 107 | 267 | ||||
Operating profit | 18,001 | 19,921 | ||||
Finance costs (Note 3) | ||||||
Interest | 2,462 | 1,148 | ||||
Other expense, net | 1,125 | 428 | ||||
3,587 | 1,576 | |||||
Earnings before income tax expense | 14,414 | 18,345 | ||||
Income tax expense (Note 4) | ||||||
Current | 988 | 2,693 | ||||
Deferred | 2,132 | 2,219 | ||||
3,120 | 4,912 | |||||
Net earnings | 11,294 | 13,433 | ||||
Net earnings (loss) attributable to: | ||||||
Company shareholders | 11,359 | 13,462 | ||||
Non-controlling interests | (65 | ) | (29 | ) | ||
11,294 | 13,433 | |||||
Earnings per share attributable to Company shareholders (Note 5) | ||||||
Basic | 0.19 | 0.23 | ||||
Diluted | 0.19 | 0.22 |
Three months ended March 31, | |||||||
2018 | 2017 | ||||||
$ | $ | ||||||
Net earnings | 11,294 | 13,433 | |||||
Other comprehensive income | |||||||
Change in fair value of interest rate swap agreements designated as cash flow hedges (1) | 1,732 | 186 | |||||
Change in cumulative translation adjustments | (586 | ) | 2,437 | ||||
Items that will be subsequently reclassified to net earnings | 1,146 | 2,623 | |||||
Comprehensive income for the period | 12,440 | 16,056 | |||||
Comprehensive income (loss) for the period attributable to: | |||||||
Company shareholders | 12,506 | 15,774 | |||||
Non-controlling interests | (66 | ) | 282 | ||||
12,440 | 16,056 |
(1) | Presented net of deferred income tax expense of $292 and $114 for the three months ended March 31, 2018 and 2017, respectively. Refer to Note 8 for additional information on the Company’s cash flow hedges. |
Accumulated other comprehensive loss | |||||||||||||||||||||||||||||
Cumulative translation adjustment account | Reserve for cash flow hedges | Total equity attributable to Company shareholders | Non-controlling interest | ||||||||||||||||||||||||||
Capital stock | Contributed Surplus | Total equity | |||||||||||||||||||||||||||
Number | Amount | Total | Deficit | ||||||||||||||||||||||||||
$ | $ | $ | $ | $ | $ | $ | $ | $ | |||||||||||||||||||||
Balance as of December 31, 2016 | 59,060,335 | 351,203 | 29,585 | (19,511 | ) | (136 | ) | (19,647 | ) | (124,605 | ) | 236,536 | 6,407 | 242,943 | |||||||||||||||
Transactions with owners | |||||||||||||||||||||||||||||
Exercise of stock options (Note 7) | 65,000 | 106 | 106 | 106 | |||||||||||||||||||||||||
Change in excess tax benefit on exercised share-based awards | 338 | (338 | ) | — | — | ||||||||||||||||||||||||
Change in excess tax benefit on outstanding share-based awards | (2,524 | ) | (2,524 | ) | (2,524 | ) | |||||||||||||||||||||||
Share-based compensation (Note 7) | (7,920 | ) | (2,814 | ) | (1) | (10,734 | ) | (10,734 | ) | ||||||||||||||||||||
Share-based compensation expense credited to capital on options exercised (Note 7) | 59 | (59 | ) | — | — | ||||||||||||||||||||||||
Dividends on common shares (Note 7) | (8,268 | ) | (8,268 | ) | (8,268 | ) | |||||||||||||||||||||||
65,000 | 503 | (10,841 | ) | (11,082 | ) | (21,420 | ) | (21,420 | ) | ||||||||||||||||||||
Net earnings (loss) | 13,462 | 13,462 | (29 | ) | 13,433 | ||||||||||||||||||||||||
Other comprehensive income | |||||||||||||||||||||||||||||
Change in fair value of interest rate swap agreements designated as cash flow hedges (2) (Note 8) | 186 | 186 | 186 | 186 | |||||||||||||||||||||||||
Change in cumulative translation adjustments | 2,126 | 2,126 | 2,126 | 311 | 2,437 | ||||||||||||||||||||||||
2,126 | 186 | 2,312 | 2,312 | 311 | 2,623 | ||||||||||||||||||||||||
Comprehensive income for the period | 2,126 | 186 | 2,312 | 13,462 | 15,774 | 282 | 16,056 | ||||||||||||||||||||||
Balance as of March 31, 2017 | 59,125,335 | 351,706 | 18,744 | (17,385 | ) | 50 | (17,335 | ) | (122,225 | ) | 230,890 | 6,689 | 237,579 |
(1) | Presented net of income tax benefit of $1,442 for the three months ended March 31, 2017. |
(2) | Presented net of deferred income tax expense of $114 for the three months ended March 31, 2017. |
Accumulated other comprehensive loss | |||||||||||||||||||||||||||||
Cumulative translation adjustment account | Reserve for cash flow hedges | Total equity attributable to Company shareholders | Non-controlling interests | ||||||||||||||||||||||||||
Capital stock | Contributed Surplus | Total equity | |||||||||||||||||||||||||||
Number | Amount | Total | Deficit | ||||||||||||||||||||||||||
$ | $ | $ | $ | $ | $ | $ | $ | $ | |||||||||||||||||||||
Balance as of December 31, 2017 | 58,799,910 | 350,759 | 17,530 | (15,057 | ) | 1,588 | (13,469 | ) | (106,687 | ) | 248,133 | 6,589 | 254,722 | ||||||||||||||||
Transactions with owners | |||||||||||||||||||||||||||||
Exercise of stock options (Note 7) | 7,500 | 70 | 70 | 70 | |||||||||||||||||||||||||
Change in excess tax benefit on exercised share-based awards | 7 | (7 | ) | — | — | ||||||||||||||||||||||||
Change in excess tax benefit on outstanding share-based awards | (152 | ) | (152 | ) | (152 | ) | |||||||||||||||||||||||
Share-based compensation (Note 7) | 60 | (183 | ) | (1) | (123 | ) | (123 | ) | |||||||||||||||||||||
Share-based compensation expense credited to capital on options exercised (Note 7) | 20 | (20 | ) | — | — | ||||||||||||||||||||||||
Dividends on common shares (Note 7) | (8,233 | ) | (8,233 | ) | (8,233 | ) | |||||||||||||||||||||||
7,500 | 97 | (119 | ) | (8,416 | ) | (8,438 | ) | (8,438 | ) | ||||||||||||||||||||
Net earnings (loss) | 11,359 | 11,359 | (65 | ) | 11,294 | ||||||||||||||||||||||||
Other comprehensive income | |||||||||||||||||||||||||||||
Change in fair value of interest rate swap agreements designated as cash flow hedges (2) (Note 8) | 1,732 | 1,732 | 1,732 | 1,732 | |||||||||||||||||||||||||
Change in cumulative translation adjustments | (585 | ) | (585 | ) | (585 | ) | (1 | ) | (586 | ) | |||||||||||||||||||
(585 | ) | 1,732 | 1,147 | 1,147 | (1 | ) | 1,146 | ||||||||||||||||||||||
Comprehensive income for the period | (585 | ) | 1,732 | 1,147 | 11,359 | 12,506 | (66 | ) | 12,440 | ||||||||||||||||||||
Balance as of March 31, 2018 | 58,807,410 | 350,856 | 17,411 | (15,642 | ) | 3,320 | (12,322 | ) | (103,744 | ) | 252,201 | 6,523 | 258,724 |
(1) | Presented net of income tax benefit of $62 for the three months ended March 31, 2018. |
(2) | Presented net of deferred income tax expense of $292 for the three months ended March 31, 2018. |
Three months ended March 31, | ||||||
2018 | 2017 | |||||
$ | $ | |||||
OPERATING ACTIVITIES | ||||||
Net earnings | 11,294 | 13,433 | ||||
Adjustments to net earnings | ||||||
Depreciation and amortization | 10,059 | 8,275 | ||||
Income tax expense | 3,120 | 4,912 | ||||
Interest expense | 2,462 | 1,148 | ||||
Share-based compensation expense | 410 | 1,188 | ||||
Loss on foreign exchange | 769 | 191 | ||||
Pension and other post-retirement expense related to defined benefit plans | 726 | 685 | ||||
Other adjustments for non-cash items | 664 | (358 | ) | |||
Income taxes paid, net | (22 | ) | (301 | ) | ||
Contributions to defined benefit plans | (512 | ) | (593 | ) | ||
Cash flows from operating activities before changes in working capital items | 28,970 | 28,580 | ||||
Changes in working capital items | ||||||
Trade receivables | (4,811 | ) | (2,230 | ) | ||
Inventories | (22,853 | ) | (9,428 | ) | ||
Parts and supplies | (477 | ) | (607 | ) | ||
Other current assets | (82 | ) | 2,445 | |||
Accounts payable and accrued liabilities and share-based compensation liabilities, current | (20,795 | ) | (28,459 | ) | ||
Provisions | (82 | ) | (879 | ) | ||
(49,100 | ) | (39,158 | ) | |||
Cash flows from operating activities | (20,130 | ) | (10,578 | ) | ||
INVESTING ACTIVITIES | ||||||
Purchases of property, plant and equipment | (18,396 | ) | (22,124 | ) | ||
Other investing activities | (156 | ) | 19 | |||
Cash flows from investing activities | (18,552 | ) | (22,105 | ) | ||
FINANCING ACTIVITIES | ||||||
Proceeds from borrowings | 101,323 | 39,511 | ||||
Repayment of borrowings | (55,236 | ) | (14,208 | ) | ||
Interest paid | (2,350 | ) | (1,208 | ) | ||
Dividends paid | (8,333 | ) | (8,316 | ) | ||
Other financing activities | 70 | 14 | ||||
Cash flows from financing activities | 35,474 | 15,793 | ||||
Net decrease in cash | (3,208 | ) | (16,890 | ) | ||
Effect of foreign exchange differences on cash | (807 | ) | 40 | |||
Cash, beginning of period | 9,093 | 20,956 | ||||
Cash, end of period | 5,078 | 4,106 |
March 31, 2018 | December 31, 2017 | |||||
(Unaudited) | (Audited) | |||||
$ | $ | |||||
ASSETS | ||||||
Current assets | ||||||
Cash | 5,078 | 9,093 | ||||
Trade receivables | 111,285 | 106,634 | ||||
Inventories | 150,151 | 128,233 | ||||
Parts and supplies | 19,007 | 18,571 | ||||
Other current assets | 16,166 | 16,188 | ||||
301,687 | 278,719 | |||||
Property, plant and equipment | 318,776 | 313,520 | ||||
Goodwill | 41,049 | 41,690 | ||||
Intangible assets | 45,801 | 47,318 | ||||
Deferred tax assets | 26,835 | 27,627 | ||||
Other assets | 10,023 | 6,998 | ||||
Total assets | 744,171 | 715,872 | ||||
LIABILITIES | ||||||
Current liabilities | ||||||
Accounts payable and accrued liabilities | 85,554 | 104,812 | ||||
Share-based compensation liabilities, current (Note 7) | 8,465 | 10,265 | ||||
Call option redemption liability (Note 8) | 12,479 | 12,725 | ||||
Provisions, current | 567 | 657 | ||||
Borrowings, current | 13,971 | 14,979 | ||||
121,036 | 143,438 | |||||
Borrowings, non-current | 309,944 | 264,484 | ||||
Pension, post-retirement and other long-term employee benefits | 29,421 | 29,298 | ||||
Share-based compensation liabilities, non-current (Note 7) | 2,220 | 4,984 | ||||
Deferred tax liabilities | 16,487 | 13,769 | ||||
Provisions, non-current | 3,211 | 3,221 | ||||
Other liabilities | 3,128 | 1,956 | ||||
485,447 | 461,150 | |||||
EQUITY | ||||||
Capital stock (Note 7) | 350,856 | 350,759 | ||||
Contributed surplus | 17,411 | 17,530 | ||||
Deficit | (103,744 | ) | (106,687 | ) | ||
Accumulated other comprehensive loss | (12,322 | ) | (13,469 | ) | ||
Total equity attributable to Company shareholders | 252,201 | 248,133 | ||||
Non-controlling interests | 6,523 | 6,589 | ||||
Total equity | 258,724 | 254,722 | ||||
Total liabilities and equity | 744,171 | 715,872 |
• | an increase in long-term assets and liabilities, due to the new requirements to record right-of-use assets and related liabilities for operating leases by lessees; |
• | an increase in cash flows from operating activities and a decrease in cash flows from financing activities, as operating lease payments will be reclassified to financing cash flows as components of interest and lease obligations; and |
• | an insignificant change to net earnings, but with reclassification of amounts between costs within operating profit and finance costs as operating lease costs are reclassified into amortization of the right-of-use asset and interest expense on the related lease obligation. |
Three months ended March 31, | ||||||
2018 | 2017 | |||||
$ | $ | |||||
Employee benefit expense | ||||||
Wages, salaries and other short-term benefits | 46,702 | 40,183 | ||||
Share-based compensation expense (Note 7) | 410 | 1,188 | ||||
Pension, post-retirement and other long-term employee benefit plans: | ||||||
Defined benefit plans | 745 | 706 | ||||
Defined contributions plans | 1,761 | 1,305 | ||||
49,618 | 43,382 | |||||
Finance costs - Interest | ||||||
Interest on borrowings | 2,484 | 1,272 | ||||
Amortization of debt issue costs on borrowings | 190 | 129 | ||||
Interest capitalized to property, plant and equipment | (212 | ) | (253 | ) | ||
2,462 | 1,148 | |||||
Finance costs - Other expense, net | ||||||
Foreign exchange loss | 769 | 191 | ||||
Other costs, net | 356 | 237 | ||||
1,125 | 428 | |||||
Additional information | ||||||
Depreciation of property, plant and equipment | 9,027 | 7,426 | ||||
Amortization of intangible assets | 1,032 | 849 | ||||
Impairment (reversal of impairment) of assets | 346 | (143 | ) |
Three months ended March 31, | ||||||||
2018 | 2017 | |||||||
Income tax expense | $ | 3,120 | $ | 4,912 | ||||
Earnings before income tax expense | $ | 14,414 | $ | 18,345 | ||||
Effective tax rate | 21.6 | % | 26.8 | % |
Three months ended March 31, | ||||||
2018 | 2017 | |||||
Basic | 58,801,327 | 59,134,017 | ||||
Effect of stock options | 345,366 | 485,266 | ||||
Effect of performance share units | — | 582,864 | ||||
Diluted | 59,146,693 | 60,202,147 |
Three months ended March 31, | |||||
2018 | 2017 | ||||
Stock options that were anti-dilutive and not included in diluted earnings per share | 242,918 | — |
Three months ended March 31, | ||||||
2018 | 2017 | |||||
PSUs which met the performance criteria (1) | — | 855,718 |
(1) | The PSU plan was amended on February 17, 2017 to provide for only cash settlement of awards. Prior to the amendment, PSUs were to be settled in common shares of the Company and were included in the calculation of weighted average diluted common shares, to the extent they were dilutive, when the applicable performance conditions had been satisfied. Subsequent to amendment, there is no impact of PSUs in the calculation of weighted average diluted common shares. |
March 31, 2018 | December 31, 2017 | |||||
$ | $ | |||||
Commitments to purchase machinery and equipment | 35,911 | 29,281 |
Declared Date | Paid date | Per common share amount | Shareholder record date | Common shares issued and outstanding | Aggregate payment (1) | |||||
March 7, 2018 | March 30, 2018 | $0.14 | March 20, 2018 | 58,807,410 | $8,333 |
(1) | The aggregate dividend payment amount presented in the table above has been adjusted for the impact of foreign exchange rates on cash payments to shareholders. |
Three Months Ended March 31, 2018 | Three Months Ended March 31, 2017 | ||||||
Weighted average exercise price | Number of options | Weighted average exercise price | Number of options | ||||
CDN$ | CDN$ | ||||||
Balance, beginning of period | 12.29 | 834,375 | 11.38 | 1,061,250 | |||
Granted | 21.76 | 242,918 | — | — | |||
Exercised | 12.04 | (7,500 | ) | 2.19 | (65,000 | ) | |
Balance, end of period | 14.44 | 1,069,793 | 11.98 | 996,250 |
Three Months Ended March 31, 2018 | |
Expected life | 4.8 years |
Expected volatility(1) | 32.09% |
Risk-free interest rate | 2.05% |
Expected dividends | 3.30% |
Stock price at grant date | CDN$21.76 |
Exercise price of awards | CDN$21.76 |
Foreign exchange rate USD to CDN | 1.2809 |
(1) | Expected volatility was calculated by applying a weighted average of the daily closing price change on the TSX for a term commensurate with the expected life of each grant. |
Three Months Ended March 31, 2018 | Three Months Ended March 31, 2017 | ||||||
Weighted average fair value | Number of PSUs | Weighted average fair value | Number of PSUs | ||||
Balance, beginning of period | 14.14 | 1,103,311 | 13.41 | 892,077 | |||
Granted | 17.84 | 284,571 | 16.15 | 358,386 | |||
Settled (1) | 16.61 | (217,860 | ) | — | — | ||
Forfeited/cancelled | — | — | 13.88 | (6,198 | ) | ||
Balance, end of period | 13.59 | 1,170,022 | 18.36 | 1,244,265 |
(1) | On March 21, 2018, the Board of Directors approved the settlement of all outstanding vested PSUs awarded on March 14, 2015. The number of PSUs vested was 100% of the Target Shares. The "Target Shares" are 100% of the PSUs granted. The cash payment on settlement was $4.0 million and included a cash payment of dividend equivalents on PSUs equaling the product that results from multiplying the number of settled PSUs by the amount of cash dividends per common share declared and paid by the Company from the date of grant of the PSUs to the settlement date. |
Grant Date | Performance | |
May 14, 2015 | 100 | % |
May 20, 2015 | 100 | % |
March 21, 2016 | 50 | % |
December 20, 2016 | 0 | % |
March 20, 2017 | 50 | % |
March 21, 2018 | 117 | % |
TSR Ranking Relative to the Peer Group | Percent of Target Shares Vested | ||
76th percentile or higher | 150 | % | |
51st-75th percentile | 100 | % | |
25th-50th percentile | 50 | % | |
Less than the 25th percentile | 0 | % |
• | 50% based on the Company's TSR ranking relative to the Peer Group over the measurement period as set out in the table below; and |
• | 50% based on the Company's average return on invested capital over the measurement period as compared to internally developed thresholds (the “ROIC Performance”) as set out in the table below. |
TSR Ranking Relative to the Peer Group | Percent of Target Shares Vested | ||
90th percentile or higher | 200 | % | |
75th percentile | 150 | % | |
50th percentile | 100 | % | |
25th percentile | 50 | % | |
Less than the 25th percentile | 0 | % |
ROIC Performance | Percent of Target Shares Vested | ||
1st Tier | 0 | % | |
2nd Tier | 50 | % | |
3rd Tier | 100 | % | |
4th Tier | 150 | % |
Three months ended March 31, | ||||||
2018 | 2017 | |||||
Expected life | 3 years | 3 years | ||||
Expected volatility(1) | 30 | % | 34 | % | ||
US risk-free interest rate | 2.43 | % | 1.57 | % | ||
Canadian risk-free interest rate | 1.96 | % | N/A | |||
Expected dividends(2) | 0 | % | 0 | % | ||
Performance period starting price(3) | CDN$21.13 | CDN$22.26 | ||||
Closing stock price on TSX as of the estimation date | CDN$20.59 | CDN$21.94 |
(1) | Expected volatility was calculated based on the daily dividend adjusted closing price change on the TSX for a term commensurate with the expected life of the grant. |
(2) | A participant will receive a cash payment from the Company upon PSU settlement that is equivalent to the number of settled PSUs multiplied by the amount of cash dividends per share declared by the Company between the date of grant and the settlement date. As such, there is no impact from expected future dividends in the Monte Carlo simulation model. |
(3) | The performance period starting price is measured as the volume weighted average price ("VWAP") for the common shares of the Company on the TSX on the grant date. |
Three Months Ended March 31, 2018 | |||
Weighted average fair value | Number of RSUs | ||
Balance, beginning of period | — | — | |
Granted | 16.29 | 113,047 | |
Balance, end of period | 15.87 | 113,047 |
Three Months Ended March 31, 2018 | Three Months Ended March 31, 2017 | ||||||
Weighted average fair value | Number of DSUs | Weighted average fair value | Number of DSUs | ||||
Balance, beginning of period | 16.91 | 167,427 | 15.04 | 119,248 | |||
Granted | 17.21 | 6,999 | 17.18 | 7,962 | |||
Balance, end of period | 15.87 | 174,426 | 17.31 | 127,210 |
Three months ended March 31, | ||||||||
2018 | 2017 | |||||||
SARs exercised | 107,500 | 13,250 | ||||||
Base price | CDN$7.56 | CDN$7.56 | ||||||
Cash payments on exercise, including awards exercised but not yet paid | $ | 1,158 | $ | 155 |
March 31, 2018 | |||
SARs outstanding | 40,000 | ||
Aggregate intrinsic value of outstanding vested awards | $ | 408 |
Three months ended March 31, | |||||
2018 | 2017 | ||||
$ | $ | ||||
Stock options | 60 | 76 | |||
PSUs | 372 | 1,278 | |||
RSUs | 59 | — | |||
DSUs | (57 | ) | 21 | ||
SARs | (24 | ) | (187 | ) | |
410 | 1,188 |
March 31, 2018 | December 31, 2017 | ||||
Share-based compensation liabilities, current | $ | $ | |||
PSUs(1) | 5,227 | 5,709 | |||
RSUs(1) | 11 | — | |||
DSUs(2) | 2,824 | 2,956 | |||
SARs | 403 | 1,600 | |||
8,465 | 10,265 | ||||
Share-based compensation liabilities, non-current | |||||
PSUs (1) | 2,172 | 4,984 | |||
RSUs(1) | 48 | — | |||
2,220 | 4,984 |
Effective Date | Maturity | Notional amount $ | Settlement | Fixed interest rate paid % | ||||||
March 18, 2015 | November 18, 2019 | 40,000 | Monthly | 1.6100 | ||||||
August 18, 2015 | August 20, 2018 | 60,000 | Monthly | 1.1970 | ||||||
June 8, 2017 | June 20, 2022 | 40,000 | Monthly | 1.7900 | ||||||
July 21, 2017 | July 18, 2022 | CDN$90,000 (1) | Monthly | 1.6825 | ||||||
August 20, 2018 | August 18, 2023 | $ | 60,000 | Monthly | 2.0450 |
(1) | The notional amount will decrease by CDN$18.0 million on the 18th of July of each year until settlement. |
Three months ended March 31, | ||||||||
2018 | 2017 | |||||||
Increase in fair value of the derivatives used for calculating hedge effectiveness | $ | 2,024 | $ | 300 |
• | On May 9, 2018, the Company declared a quarterly cash dividend of $0.14 per common share payable on June 29, 2018 to shareholders of record at the close of business on June 15, 2018. The estimated amount of this dividend payment is $8.2 million based on 58,807,410 of the Company’s common shares issued and outstanding as of May 9, 2018. |
1. | Review: I have reviewed the interim financial report and interim MD&A (together, the “interim filings”) of INTERTAPE POLYMER GROUP INC./LE GROUPE INTERTAPE POLYMER INC. (the “Issuer”) for the interim period ended March 31, 2018. |
2. | No misrepresentation: Based on my knowledge, having exercised reasonable diligence, the interim filings do not contain any untrue statement of a material fact or omit to state a material fact required to be stated or that is necessary to make a statement not misleading in light of the circumstances under which it was made, with respect to the period covered by the interim filings. |
3. | Fair presentation: Based on my knowledge, having exercised reasonable diligence, the interim financial report together with the other financial information included in the interim filings fairly present in all material respects the financial condition, financial performance and cash flows of the Issuer, as of the date and for the periods presented in the interim filings. |
4. | Responsibility: The Issuer’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (DC&P) and internal control over financial reporting (ICFR), as those terms are defined in National Instrument 52 - 109 Certification of Disclosure in Issuers’ Annual and Interim Filings, for the Issuer. |
5. | Design: Subject to the limitations, if any, described in paragraphs 5.2 and 5.3, the Issuer’s other certifying officer(s) and I have, as at the end of the period covered by the interim filings: |
(a) | designed DC&P, or caused it to be designed under our supervision, to provide reasonable assurance that |
(a) | material information relating to the Issuer is made known to us by others, particularly during the period in which the interim filings are being prepared; and |
(b) | information required to be disclosed by the Issuer in its annual filings, interim filings or other reports filed or submitted by it under securities legislation is recorded, processed, summarized and reported within the time periods specified in securities legislation; and |
(b) | designed ICFR, or caused it to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with the Issuer’s GAAP. |
5.1 | Control framework: The control framework the Issuer’s other certifying officer(s) and I used to design the Issuer’s ICFR is the 2013 Internal Control – Integrated Framework published by the Committee of Sponsoring Organization of the Treadway Commission (COSO). |
5.2 | ICFR – material weakness relating to design: N/A |
5.3 | Limitation on scope of design: The issuer has disclosed in its interim MD&A |
(a) | the fact that the issuer’s other certifying officer(s) and I have limited the scope of our design of DC&P and ICFR to exclude controls, policies and procedures of: |
(b) | summary financial information about business that the issuer acquired that has been consolidated in the issuer’s financial statements. |
6. | Reporting changes in ICFR: The Issuer has disclosed in the interim MD&A any change in the Issuer’s ICFR that occurred during the period beginning on January 1, 2018 and ended on March 31, 2018 that has materially affected, or is reasonably likely to materially affect, the Issuer’s ICFR. |
1. | Review: I have reviewed the interim financial report and interim MD&A (together, the “interim filings”) of INTERTAPE POLYMER GROUP INC./LE GROUPE INTERTAPE POLYMER INC. (the “Issuer”) for the interim period ended March 31, 2018. |
2. | No misrepresentation: Based on my knowledge, having exercised reasonable diligence, the interim filings do not contain any untrue statement of a material fact or omit to state a material fact required to be stated or that is necessary to make a statement not misleading in light of the circumstances under which it was made, with respect to the period covered by the interim filings. |
3. | Fair presentation: Based on my knowledge, having exercised reasonable diligence, the interim financial report together with the other financial information included in the interim filings fairly present in all material respects the financial condition, financial performance and cash flows of the Issuer, as of the date and for the periods presented in the interim filings. |
4. | Responsibility: The Issuer’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (DC&P) and internal control over financial reporting (ICFR), as those terms are defined in National Instrument 52 - 109 Certification of Disclosure in Issuers’ Annual and Interim Filings, for the Issuer. |
5. | Design: Subject to the limitations, if any, described in paragraphs 5.2 and 5.3, the Issuer’s other certifying officer(s) and I have, as at the end of the period covered by the interim filings: |
(a) | designed DC&P, or caused it to be designed under our supervision, to provide reasonable assurance that |
(a) | material information relating to the Issuer is made known to us by others, particularly during the period in which the interim filings are being prepared; and |
(b) | information required to be disclosed by the Issuer in its annual filings, interim filings or other reports filed or submitted by it under securities legislation is recorded, processed, summarized and reported within the time periods specified in securities legislation; and |
(b) | designed ICFR, or caused it to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with the Issuer’s GAAP. |
5.1 | Control framework: The control framework the Issuer’s other certifying officer(s) and I used to design the Issuer’s ICFR is the 2013 Internal Control – Integrated Framework published by the Committee of Sponsoring Organization of the Treadway Commission (COSO). |
5.3 | Limitation on scope of design: The issuer has disclosed in its interim MD&A |
a. | the fact that the issuer’s other certifying officer(s) and I have limited the scope of our design of DC&P and ICFR to exclude controls, policies and procedures of: |
b. | summary financial information about business that the issuer acquired that has been consolidated in the issuer’s financial statements. |
6. | Reporting changes in ICFR: The Issuer has disclosed in the interim MD&A any change in the Issuer’s ICFR that occurred during the period beginning on January 1, 2018 and ended on March 31, 2018 that has materially affected, or is reasonably likely to materially affect, the Issuer’s ICFR. |